Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | |
---|---|---|---|---|
1 | 2 | |||
Agranulocytosis | x | x | ||
Aplastic anaemia | x | x | ||
Haemolytic anaemia | x | x | ||
Muscle contracture | x | x | ||
Dermatitis exfoliative | x | x | ||
Erythema multiforme | x | x | ||
Rash | x | x | ||
Blood disorder | x | x | ||
Hepatitis | x | x | ||
Hypersensitivity | x | x | ||
Leukopenia | x | x | ||
Nephritis interstitial | x | x | ||
Nephrosis | x | x | ||
Separation | x | x | ||
Stevens-Johnson syndrome | x | x | ||
Thrombocytopenia | x | x | ||
Burning sensation | x | x | ||
Hepatic necrosis | x | x | ||
Skin necrosis | x | x | ||
Skin discolouration | x | x | ||
Sepsis | x | x | ||
Reaction gastrointestinal | x | x | ||
Bacterial colonisation | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | |||
---|---|---|---|---|
Burns third degree | x | x | ||
Wound sepsis | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |